Methadone dosage for prevention of opioid withdrawal in children.
about
Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocolA systematic review of the cardiotoxicity of methadoneOpioid analgesia in mechanically ventilated children: results from the multicenter Measuring Opioid Tolerance Induced by Fentanyl studyTolerance and withdrawal from prolonged opioid use in critically ill children.Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children.Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.Methadone use in children and young adults at a cancer center: a retrospective study.Patterns of Sedation Weaning in Critically Ill Children Recovering From Acute Respiratory Failure.Defining sedation-related adverse events in the pediatric intensive care unitOpioid analgesia in neonates following cardiac surgery.Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model.Conversion from prolonged intravenous fentanyl infusion to enteral methadone in critically ill children.Impact of a Standardized Treatment Guideline for Pediatric Iatrogenic Opioid Dependence: A Quality Improvement Initiative.The use of methadone to facilitate opioid weaning in pediatric critical care patients: a systematic review of the literature and meta-analysis.Use of methadone for opioid weaning in children: prescribing practices and trends.Use of methadone for prevention of opioid withdrawal in critically ill children.Evaluation of adverse events noted in children receiving continuous infusions of dexmedetomidine in the intensive care unitExternal validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome.Prolonged infusion of dexmedetomidine for sedation following tracheal resection.Caregiver Perception, Self-efficacy, and Knowledge of Methadone Tapers for Children With Iatrogenic Opioid Abstinence Syndrome.
P2860
Q24562964-9E46C858-414B-4615-9BA3-F6393F8AEF8FQ26766513-F7A3B1D9-0C32-470F-8FAB-43045CD41122Q30415572-8924E166-A0DB-4207-9255-F8AA7BCC3218Q30428413-4CA376C8-852F-4DE8-B25B-AE7F7CC9D8C7Q34185320-10A307E3-6394-4810-B468-4420A62CF543Q34419506-F8A8F127-35A5-4092-B54A-49E5299238CCQ35456161-7AAE6C61-279E-4EC5-8AB2-58D2E3BE400BQ36437272-0EC16382-BA94-4B08-969D-BCB054F30908Q36811188-DA65AF11-688F-4646-B420-670299CCFC14Q36813077-AA542102-C449-4AAD-A3EA-2B8CD1318594Q38307985-312A993A-7ADD-4827-838C-6D5AC6036C20Q38766195-0F7B4B56-B7EF-49DA-A217-B7B61A94B2FAQ38782833-FE99DFB1-1297-48F6-B462-97DED865B71DQ39008592-D562B9AF-8EDB-488E-A6D1-2A3A7CAC33ACQ39127248-D01CAF6F-A47F-49DD-9325-39165BE992A7Q41262691-6DD38847-35E2-4859-AFA8-247083E0E033Q41680816-03B8F128-2A5E-4055-9CCD-148ED5A3435BQ44342124-6757DB3D-5BCE-479B-B100-88E646784A34Q46550570-C7CB6410-8303-483C-8EE3-7BE37E93CB58Q55282649-1DF3837E-03CA-4EBC-A32B-7DE1F7734D65
P2860
Methadone dosage for prevention of opioid withdrawal in children.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Methadone dosage for prevention of opioid withdrawal in children.
@ast
Methadone dosage for prevention of opioid withdrawal in children.
@en
type
label
Methadone dosage for prevention of opioid withdrawal in children.
@ast
Methadone dosage for prevention of opioid withdrawal in children.
@en
prefLabel
Methadone dosage for prevention of opioid withdrawal in children.
@ast
Methadone dosage for prevention of opioid withdrawal in children.
@en
P2093
P1476
Methadone dosage for prevention of opioid withdrawal in children.
@en
P2093
Andrew M B Heard
Christopher M B Heard
Donna Kielma
James E Fletcher
Michael Cimino
Rajashekhar Siddappa
P2860
P304
P356
10.1046/J.1460-9592.2003.01153.X
P577
2003-11-01T00:00:00Z